Zymeworks Q1 2024 GAAP EPS $(0.42) Misses $(0.29) Estimate, Sales $10.030M Miss $17.431M Estimate
Zymeworks Q1 2024 GAAP EPS $(0.42) Misses $(0.29) Estimate, Sales $10.030M Miss $17.431M Estimate
Zymeworks 2024 年第一季度公認會計准則每股收益 (0.42) 未達到預期 (0.29) 美元，銷售額爲 100.3 億美元，低於預期 174.31 億美元
Zymeworks (NYSE:ZYME) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.29) by 44.83 percent. This is a 13.51 percent decrease over losses of $(0.37) per share from the same period last year. The company reported quarterly sales of $10.030 million which missed the analyst consensus estimate of $17.431 million by 42.46 percent. This is a 71.81 percent decrease over sales of $35.578 million the same period last year.
Zymeworks（紐約證券交易所代碼：ZYME）公佈的季度虧損爲每股0.42美元，比分析師普遍預期的0.29美元（0.29美元）低44.83％。這比去年同期每股虧損0.37美元（0.37）下降了13.51％。該公司公佈的季度銷售額爲100.3億美元，比分析師普遍預期的1743.1萬美元低42.46％。這比去年同期的355.78萬美元的銷售額下降了71.81％。